For the short term management of mild to moderate acute pain and the reduction of fever
Pour la gestion à court terme de la douleur aiguë légère à modérée et la réduction de la fièvre

On November 25, 2019, the Company signed a License and Exclusive Supply Agreement with AFT Pharmaceuticals Ltd for Combogesic^®, which combines two pain relief medicines in a single form. Health Canada approved the first form of Combogesic^® In 2019. The Company is currently preparing for the launch of this product to the Canadian market.